271 related articles for article (PubMed ID: 34802772)
21. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
[TBL] [Abstract][Full Text] [Related]
22. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
Shastry S; Manini AF; Richardson LD; Lin MP
J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
[No Abstract] [Full Text] [Related]
23. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
Williams AR; Samples H; Crystal S; Olfson M
Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
[TBL] [Abstract][Full Text] [Related]
24. Death after emergency department visits for opioid overdose in British Columbia: a retrospective cohort analysis.
Moe J; Chong M; Zhao B; Scheuermeyer FX; Purssell R; Slaunwhite A
CMAJ Open; 2021; 9(1):E242-E251. PubMed ID: 33731425
[TBL] [Abstract][Full Text] [Related]
25. Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018.
Barenie RE; Gagne JJ; Kesselheim AS; Pawar A; Tong A; Luo J; Bateman BT
Drug Saf; 2020 Jul; 43(7):669-675. PubMed ID: 32180134
[TBL] [Abstract][Full Text] [Related]
26. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
27. Predictors of receiving an emergency department naloxone prescription following an opioid overdose.
Lebin JA; Huynh L; Morse SC; Jablonowksi K; Hall J; Whiteside LK
Am J Emerg Med; 2021 Aug; 46():763-764. PubMed ID: 32972794
[No Abstract] [Full Text] [Related]
28. Trends in naloxone prescribed at emergency department discharge: A national analysis (2012-2019).
Ramdin C; Chandran K; Nelson L; Mazer-Amirshahi M
Am J Emerg Med; 2023 Mar; 65():162-167. PubMed ID: 36638613
[TBL] [Abstract][Full Text] [Related]
29. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
Hu T; Snider-Adler M; Nijmeh L; Pyle A
CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
[TBL] [Abstract][Full Text] [Related]
31. Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation.
Belden C; Kopak A; Coules C; Friesen T; Hall J; Shukla S
J Subst Use Addict Treat; 2024 Jul; 162():209364. PubMed ID: 38626851
[TBL] [Abstract][Full Text] [Related]
32. Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.
Holland WC; Nath B; Li F; Maciejewski K; Paek H; Dziura J; Rajeevan H; Lu CC; Katsovich L; D'Onofrio G; Melnick ER
Acad Emerg Med; 2020 Aug; 27(8):753-763. PubMed ID: 32352206
[TBL] [Abstract][Full Text] [Related]
33. Multi-site intervention to improve emergency department care for patients who live with opioid use disorder: A quantitative evaluation.
McLane P; Scott K; Suleman Z; Yee K; Holroyd BR; Dong K; Ghosh SM; Fanaeian J; Deol J; Biggs C; Lang E; ; Hair H; Ross M; Tanguay R; Olmstead A; Fisher A; Fielding S
CJEM; 2020 Nov; 22(6):784-792. PubMed ID: 32924911
[TBL] [Abstract][Full Text] [Related]
34. Identifying barriers to emergency department-initiated buprenorphine: A spatial analysis of treatment facility access in Michigan.
Dora-Laskey A; King A; Sadler R
Am J Emerg Med; 2022 Jan; 51():393-396. PubMed ID: 34826787
[TBL] [Abstract][Full Text] [Related]
35. Opioid-related Policies in New England Emergency Departments.
Weiner SG; Raja AS; Bittner JC; Curtis KM; Weimersheimer P; Hasegawa K; Espinola JA; Camargo CA
Acad Emerg Med; 2016 Sep; 23(9):1086-90. PubMed ID: 27098615
[TBL] [Abstract][Full Text] [Related]
36. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
[No Abstract] [Full Text] [Related]
37. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
38. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
[TBL] [Abstract][Full Text] [Related]
39. Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.
Kazerouni NJ; Irwin AN; Levander XA; Geddes J; Johnston K; Gostanian CJ; Mayfield BS; Montgomery BT; Graalum DC; Hartung DM
Drug Alcohol Depend; 2021 Jul; 224():108729. PubMed ID: 33932744
[TBL] [Abstract][Full Text] [Related]
40. The effect of untargeted naloxone distribution on opioid overdose outcomes.
Dowd WN
Health Econ; 2023 Dec; 32(12):2801-2818. PubMed ID: 37670413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
